Search - tctmd.com

Displaying 761 - 780 of 881

Sort: Relevancy | Date

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Industry News

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

August 24, 2012

News Industry News

Cardiac Ablation Technology will be Featured during Scientific Sessions and Academic Symposium

August 22, 2012

News Daily News

Post-TAVR Transfusion Tied to Increased Mortality

August 16, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

Presentation

Indirect Comparisons of New Oral Anticoagulant Drugs When Used for Stroke Prevention in A-fib

Presenter: GYH Lip

August 13, 2012

Presentation

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in A-fib Patients Following MI and PCI

Presenter: M. Lamberts

August 10, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Infection After Primary PCI Rare but Serious

August 07, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

Presentation

Does the Left Atrial Appendage Morphology Correlate with Stroke Risk in Patients with A-fib?

Presenter: L. Di Biase

July 30, 2012

News Daily News

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

L.A. McKeown

July 18, 2012

News Daily News

La Anticoagulación Protege a aquellos Pacientes con FA que se someten a PCI, a pesar del Riesgo Hemorrágico

Caitlin E. Cox

July 16, 2012

News Daily News

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

Caitlin E. Cox

July 16, 2012

Presentation

Oral Anticoagulation Therapy in A-Fib Pts at High Bleeding Risk Undergoing Coronary Artery Stenting

Presenter: 204943|JM Ruiz-Nodar

July 13, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Advertisement

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

Cardiac Ablation Technology will be Featured during Scientific Sessions and Academic Symposium

Post-TAVR Transfusion Tied to Increased Mortality

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

Indirect Comparisons Show Little Difference Among New Anticoagulants

Indirect Comparisons of New Oral Anticoagulant Drugs When Used for Stroke Prevention in A-fib

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in A-fib Patients Following MI and PCI

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Infection After Primary PCI Rare but Serious

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

Does the Left Atrial Appendage Morphology Correlate with Stroke Risk in Patients with A-fib?

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

La Anticoagulación Protege a aquellos Pacientes con FA que se someten a PCI, a pesar del Riesgo Hemorrágico

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

Oral Anticoagulation Therapy in A-Fib Pts at High Bleeding Risk Undergoing Coronary Artery Stenting

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content